A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study
Judith J. Prochaska(Stanford University), Athena Robinson(Cabot (United States)), Erin A. Vogel(Stanford University), Michael Baiocchi(Stanford University), Matthew S. Kendra(Stanford University), Sarah Pajarito(Wolters Kluwer Health), Amy Chieng(Stanford University)
Cited by 257
Related Papers
Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies
|Circulation|2013|407
Evidence of Human-Level Bonds Established With a Digital Conversational Agent: Cross-sectional, Retrospective Observational Study
|JMIR Formative Research|2021|220
What variables are associated with successful weight loss outcomes for bariatric surgery after 1 year?
|Surgery for Obesity and Related Diseases|2014|100
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic
|Drug and Alcohol Dependence|2021|92
Applying family‐based treatment (FBT) to three clinical presentations of avoidant/restrictive food intake disorder: Similarities and differences from FBT for anorexia nervosa
|International Journal of Eating Disorders|2018|89